1999•Dementia and Geriatric Cognitive DisordersRequires access

Lack of Genetic Associations of Alpha-1-Antichymotrypsin Polymorphism with Alzheimer-Type Neuropathological Changes or Sporadic Alzheimer’s Disease

Nobuyuki Sodeyama, Masahito Yamada, Yoshinori Itoh, Naomi Suematsu, Masaaki Matsushita, E Otomo, Hidehiro Mizusawa

Abstract

To elucidate the influence of the alpha1-antichymotrypsin (ACT) polymorphism on Alzheimer-type neuropathological changes and the development of sporadic Alzheimer's disease (AD), we studied the relationship between the ACT polymorphism and the severity of Alzheimer-type neuropathological changes in the brains from AD patients and nondemented subjects. There was no association of the ACT polymorphism with Alzheimer-type neuropathological changes in AD or nondemented individuals. ACT polymorphism was not associated with the development of AD. These results remained nonsignificant when the ACT genotype groups were divided into subgroups according to the apolipoprotein E (ApoE) epsiolon4 status. Our study shows that the ACT polymorphism has no effect on Alzheimer-type neuropathological changes or the development of AD, either alone or in combination with ApoE epsiolon4.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Alzheimer's disease, Degenerative disease, Disease, Dementia, Central nervous system disease, Polymorphism (computer science), Neuropathology, Neuroscience